[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100572215":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":59,"centralContacts":63,"locations":70,"responsibleParty":298,"collaborators":11,"id":301,"slug":11,"hasResults":302,"nctId":303,"briefTitle":304,"officialTitle":305,"acronym":11,"eligibilityCriteria":306,"healthyVolunteers":302,"sex":307,"minAge":308,"maxAge":309,"enrollmentInfo":310,"targetDuration":11,"studyType":313,"phases":314,"briefSummary":316,"conditions":317,"keywords":11,"overallStatus":73,"whyStopped":11,"lastUpdateSubmitDate":321,"lastUpdatePostDateStruct":322,"startDateStruct":325,"completionDateStruct":327,"leadSponsor":329,"locationsCount":330},{"fullName":5,"class":6},"Qilu Hospital of Shandong University","OTHER",[8,16],{"label":9,"type":10,"description":11,"interventionNames":12},"Disitamab Vedotin+Sintilimab+S-1","EXPERIMENTAL",null,[13,14,15],"Drug: Disitamab Vedotin","Drug: Sintilimab","Drug: S-1",{"label":17,"type":18,"description":11,"interventionNames":19},"Trastuzumab+Chemotherapy（XELOX\u002FFP\u002FXP) ± Sintilimab","ACTIVE_COMPARATOR",[14,20,21,22,23,24],"Drug: Trastuzumab","Drug: Oxaliplatin","Drug: Capecitabine","Drug: 5-FU","Drug: Cisplatin",[26,31,35,39,43,47,51,55],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":11},"DRUG","Disitamab Vedotin","2.5 mg\u002Fkg IV every 3 weeks",[9],{"type":27,"name":32,"description":33,"armGroupLabels":34,"otherNames":11},"Sintilimab","200 mg IV every 3 weeks",[9,17],{"type":27,"name":36,"description":37,"armGroupLabels":38,"otherNames":11},"S-1","40-60 mg BID for 14 days, every 3 weeks",[9],{"type":27,"name":40,"description":41,"armGroupLabels":42,"otherNames":11},"Trastuzumab","First load dose is 8.0mg\u002Fkg , then 6.0 mg\u002Fkg IV every 3 weeks",[17],{"type":27,"name":44,"description":45,"armGroupLabels":46,"otherNames":11},"Oxaliplatin","130 mg\u002Fm2 Q3W",[17],{"type":27,"name":48,"description":49,"armGroupLabels":50,"otherNames":11},"Capecitabine","1000 mg\u002Fm² Q3W",[17],{"type":27,"name":52,"description":53,"armGroupLabels":54,"otherNames":11},"5-FU","800 mg\u002Fm²",[17],{"type":27,"name":56,"description":57,"armGroupLabels":58,"otherNames":11},"Cisplatin","80 mg\u002Fm²",[17],[60],{"name":61,"affiliation":5,"role":62},"Lian Liu, MD","STUDY_CHAIR",[64,68],{"name":61,"role":65,"phone":66,"phoneExt":11,"email":67},"CONTACT","0531-82169851","tounao@126.com",{"name":69,"role":65,"phone":66,"phoneExt":11,"email":11},"Song Li, MD",[71,92,105,118,134,144,154,162,173,184,195,209,217,223,230,244,255,267,277,290],{"facility":72,"status":73,"city":74,"state":75,"zip":76,"country":77,"cosmosGeoPoint":78,"geoPoint":83,"contacts":84},"The First Affiliated Hospital of Zhengzhou University","RECRUITING","Zhengzhou","Henan","450052","China",{"type":79,"coordinates":80},"Point",[81,82],113.64861,34.75778,{"lat":82,"lon":81},[85,89],{"name":86,"role":65,"phone":87,"phoneExt":11,"email":88},"Yongxu Jia, MD","+86 15237128281","jiayongxu111@126.com",{"name":90,"role":65,"phone":11,"phoneExt":11,"email":91},"Yanru Qin, MD","yanruqin@163.com",{"facility":93,"status":94,"city":95,"state":96,"zip":11,"country":77,"cosmosGeoPoint":97,"geoPoint":101,"contacts":102},"Binzhou Medical University Hospital","NOT_YET_RECRUITING","Binzhou","Shandong",{"type":79,"coordinates":98},[99,100],118.01667,37.36667,{"lat":100,"lon":99},[103],{"name":104,"role":65,"phone":11,"phoneExt":11,"email":11},"Feng Wang",{"facility":106,"status":73,"city":107,"state":96,"zip":11,"country":77,"cosmosGeoPoint":108,"geoPoint":112,"contacts":113},"Shengli Oilfield Central Hospital","Dongying",{"type":79,"coordinates":109},[110,111],118.49165,37.46271,{"lat":111,"lon":110},[114],{"name":115,"role":65,"phone":116,"phoneExt":11,"email":117},"Tingting Zhang, MD","18766757077","ztt850426@163.com",{"facility":119,"status":73,"city":120,"state":96,"zip":121,"country":77,"cosmosGeoPoint":122,"geoPoint":126,"contacts":127},"Shandong Provincial Hospital Affiliated to Shandong First Medical University","Jinan","250012",{"type":79,"coordinates":123},[124,125],116.99722,36.66833,{"lat":125,"lon":124},[128,132],{"name":129,"role":65,"phone":130,"phoneExt":11,"email":131},"Lei Cong, MD","15168889208","wdconglei@163.com",{"name":129,"role":133,"phone":11,"phoneExt":11,"email":11},"PRINCIPAL_INVESTIGATOR",{"facility":135,"status":73,"city":120,"state":96,"zip":121,"country":77,"cosmosGeoPoint":136,"geoPoint":138,"contacts":139},"Shandong Provincial Third Hospital",{"type":79,"coordinates":137},[124,125],{"lat":125,"lon":124},[140],{"name":141,"role":65,"phone":142,"phoneExt":11,"email":143},"Kainan Li, Doctor","15053125301","lkn_bean@163.com",{"facility":145,"status":73,"city":120,"state":96,"zip":121,"country":77,"cosmosGeoPoint":146,"geoPoint":148,"contacts":149},"Shandong Univerisity Qilu Hospital",{"type":79,"coordinates":147},[124,125],{"lat":125,"lon":124},[150],{"name":151,"role":65,"phone":152,"phoneExt":11,"email":153},"Lian Liu, MD, PhD","18560082903","lianliu@sdu.edu.cn",{"facility":155,"status":73,"city":120,"state":96,"zip":11,"country":77,"cosmosGeoPoint":156,"geoPoint":158,"contacts":159},"Jinan Third People's Hospital",{"type":79,"coordinates":157},[124,125],{"lat":125,"lon":124},[160],{"name":161,"role":65,"phone":11,"phoneExt":11,"email":11},"Zupeng Luan",{"facility":163,"status":73,"city":164,"state":96,"zip":11,"country":77,"cosmosGeoPoint":165,"geoPoint":169,"contacts":170},"Affiliated Hospital of Jining Medical College","Jining",{"type":79,"coordinates":166},[167,168],116.58139,35.405,{"lat":168,"lon":167},[171],{"name":172,"role":65,"phone":11,"phoneExt":11,"email":11},"Junye Wang, MD",{"facility":174,"status":73,"city":175,"state":96,"zip":11,"country":77,"cosmosGeoPoint":176,"geoPoint":180,"contacts":181},"Liaocheng People's Hospital","Liaocheng",{"type":79,"coordinates":177},[178,179],116.00247,36.45064,{"lat":179,"lon":178},[182],{"name":183,"role":65,"phone":11,"phoneExt":11,"email":11},"Baozhong Wang",{"facility":185,"status":73,"city":186,"state":96,"zip":11,"country":77,"cosmosGeoPoint":187,"geoPoint":191,"contacts":192},"Linyi Cancer Hospital","Linyi",{"type":79,"coordinates":188},[189,190],118.34278,35.06306,{"lat":190,"lon":189},[193],{"name":194,"role":65,"phone":11,"phoneExt":11,"email":11},"Zhen Li",{"facility":196,"status":73,"city":197,"state":96,"zip":198,"country":77,"cosmosGeoPoint":199,"geoPoint":203,"contacts":204},"Qilu Hospital of Shandong University(Qingdao)","Qingdao","250063",{"type":79,"coordinates":200},[201,202],120.38042,36.06488,{"lat":202,"lon":201},[205],{"name":206,"role":65,"phone":207,"phoneExt":11,"email":208},"Fangli Cao, MD","18561811170","qdsunying@foxmail.com",{"facility":210,"status":94,"city":197,"state":96,"zip":11,"country":77,"cosmosGeoPoint":211,"geoPoint":213,"contacts":214},"The Affiliated Hospital of Qingdao University",{"type":79,"coordinates":212},[201,202],{"lat":202,"lon":201},[215],{"name":216,"role":65,"phone":11,"phoneExt":11,"email":11},"Zimin Liu",{"facility":218,"status":94,"city":219,"state":96,"zip":11,"country":77,"cosmosGeoPoint":11,"geoPoint":11,"contacts":220},"Taian City Central Hospital","Taian",[221],{"name":222,"role":65,"phone":11,"phoneExt":11,"email":11},"Li Meng, MD",{"facility":224,"status":73,"city":219,"state":96,"zip":11,"country":77,"cosmosGeoPoint":11,"geoPoint":11,"contacts":225},"The Second Affiliated Hospital of Shandong First Medical University",[226],{"name":227,"role":65,"phone":228,"phoneExt":11,"email":229},"Haiyan Liu, MD","13001770627","Fylhy1998@163.com",{"facility":231,"status":73,"city":232,"state":96,"zip":233,"country":77,"cosmosGeoPoint":234,"geoPoint":238,"contacts":239},"Tengzhou Central People's Hospital","Tengzhou","277599",{"type":79,"coordinates":235},[236,237],117.19071,35.08357,{"lat":237,"lon":236},[240],{"name":241,"role":65,"phone":242,"phoneExt":11,"email":243},"Ling Li, MD","13863260929","lilingtz@163.com",{"facility":245,"status":94,"city":246,"state":96,"zip":11,"country":77,"cosmosGeoPoint":247,"geoPoint":251,"contacts":252},"Weifang Hospital of Traditional Chinese Medicine","Weifang",{"type":79,"coordinates":248},[249,250],119.10194,36.71,{"lat":250,"lon":249},[253],{"name":254,"role":65,"phone":11,"phoneExt":11,"email":11},"Zhonghai Du",{"facility":256,"status":73,"city":257,"state":96,"zip":11,"country":77,"cosmosGeoPoint":258,"geoPoint":262,"contacts":263},"Yantai Yuhuangding Hospital","Yantai",{"type":79,"coordinates":259},[260,261],121.44081,37.47649,{"lat":261,"lon":260},[264],{"name":265,"role":65,"phone":11,"phoneExt":11,"email":266},"Aina Liu","nana4312@sina.com",{"facility":268,"status":73,"city":257,"state":96,"zip":11,"country":77,"cosmosGeoPoint":269,"geoPoint":271,"contacts":272},"Yantaishan Hospital",{"type":79,"coordinates":270},[260,261],{"lat":261,"lon":260},[273],{"name":274,"role":65,"phone":275,"phoneExt":11,"email":276},"Dongmei Zhou, MD","13953590373","zhoudongmei68@163.com",{"facility":278,"status":73,"city":279,"state":96,"zip":11,"country":77,"cosmosGeoPoint":280,"geoPoint":284,"contacts":285},"Zibo Central Hospital","Zibo",{"type":79,"coordinates":281},[282,283],118.06333,36.79056,{"lat":283,"lon":282},[286],{"name":287,"role":65,"phone":288,"phoneExt":11,"email":289},"Yi Zhai, MD","18678186991","zhai-yi@21cn.com",{"facility":291,"status":73,"city":279,"state":96,"zip":11,"country":77,"cosmosGeoPoint":292,"geoPoint":294,"contacts":295},"Zibo First People's Hospital",{"type":79,"coordinates":293},[282,283],{"lat":283,"lon":282},[296],{"name":297,"role":65,"phone":11,"phoneExt":11,"email":11},"Fei Ding",{"type":133,"investigatorFullName":299,"investigatorTitle":300,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"Lian Liu, MD, PHD","Director","100572215",false,"NCT06730373","First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)","A Phase II, Open-Label, Multicenter Trial Comparing Disitamab Vedotin Plus Sintilimab and S-1 With Trastuzumab Plus Chemotherapy ± Sintilimab for First-Line Treatment of HER2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (RCTS2)","Inclusion Criteria:\n\n1. Aged18-75 years, gender is not limited;\n2. Pathologically confirmed locally advanced gastric or gastroesophageal junction adenocarcinoma that is inoperable or has distant metastasis;\n3. HER2-Positive (IHC3+or IHC2+\u002FFISH+) ;\n4. Has at least 1 measurable lesion as determined by RECIST 1.1;\n5. There is no systematic treatment in the past, or the patient has received neoadjuvant\u002Fadjuvant chemotherapy, but the disease progresses or relapses more than 6 months after the end of treatment;\n6. Eastern Cooperative Oncology Group (ECOG) performance status of 0-1;\n7. Adequate organ function;\n8. The life expectancy is at least 3 months;\n\nExclusion Criteria:\n\n1. Allergy to any trial drug and its excipients, or serious allergy history, or contraindication of the trial drug;\n2. Cardiovascular and cerebrovascular events that are not well controlled;\n3. Has received systematic treatment with Chinese patent medicine or immunomodulatory drugs (including thymosin, interferon, interleukin, except for local use for ascites control) before the first administration within 2 weeks.\n4. Have a history of interstitial lung disease, non-infectious pneumonia, pulmonary fibrosis, acute lung disease, or systemic disease with poor control (including but not limited to diabetes, hypertension, etc.);\n5. Have a history of active immune deficiency or autoimmune diseases, including HIV positive test, or have other acquired or congenital immune deficiency diseases, or have a history of organ transplantation or autoimmune diseases;\n6. Severe chronic or active infection requires systemic antibacterial, antifungal or antiviral treatment, including tuberculosis infection.Have a history of active tuberculosis infection ≥ 1 year before recruitment should also be excluded, unless proved has been completed appropriate treatment;\n7. Brain metastasis or leptomeningeal metastasis;\n8. Clinically significant pleural effusion, pericardial effusion or ascites should be drained for many times within 2 weeks before the first administration of the trial drug;\n9. Has a second clinically detectable primary malignant tumor at the time of recruitment, or there were other malignant tumors in the past 5 years (except for fully treated skin basal cell carcinoma or cervical carcinoma in situ);\n10. Any major surgery was performed ≤ 28 days before the first trial drug administration;\n11. History of allogeneic stem cell transplantation or organ transplantation;","ALL","18 Years","75 Years",{"count":311,"type":312},110,"ESTIMATED","INTERVENTIONAL",[315],"PHASE2","This is a Phase II, randomized, multicenter, open-label clinical trial designed to compare Disitamab Vedotin plus Sintilimab and S-1 with Trastuzumab plus chemotherapy ± Sintilimab for first-line treatment of HER2-Positive advanced gastric or gastroesophageal junction adenocarcinoma.",[318,319,320],"HER2-positive Gastric Cancer","Metastatic Gastric Cancer","Unresectable Gastric Carcinoma","2024-12-29",{"date":323,"type":324},"2024-12-31","ACTUAL",{"date":326,"type":324},"2024-10-17",{"date":328,"type":312},"2027-12-31",{"name":5,"class":6},20]